Recent Headlines
AdvantaPure(R) Announces Fall Trade Show Appearances - Includes Events in the Northeast U.S.
AdvantaPure, the high purity division of NewAge Industries, will exhibit its silicone and TPE tubing and molded assemblies at the ISPE Boston Show, BioProcess International 2021, and Interphex, all taking place in September and October. AdvantaPure will also highlight its recent clean room expansion and its in-process building renovation at the events. The company is increasing its tubing manufacturing capacity to help meet demand for its Single-Use products. - September 16, 2021 - AdvantaPure
MEDraysintell Publishes the 8th Edition of Its Nuclear Medicine Report & Directory
A set of three volumes (3,100 pages) with a description of 870 products, together with a comprehensive profile of 340 companies active around the world in the radiopharmaceutical industry. - September 16, 2021 - MEDraysintell
Synformulas Presents the Scientifically Researched Potential of Its Products for the First Time at Vitafoods Europe
Common diseases such as gastrointestinal conditions and allergies are the focus of the company’s research and product development; More value is being added for further licensing and distribution partners through strong scientific research results; SYNformulas is seeking for additional distribution partners to expand its internationalization activities with its patented active complexes. - September 13, 2021 - SYNformulas
Mirror Biologics, Inc. Announces Initial Clearance for Phase II/III Clinical Trial (ALIVE) in Advanced Liver Cancer
Mirror Biologics, Inc, (“Mirror Biologics” or the “Company”), a clinical stage immunotherapy company specializing in the development, manufacturing and clinical translation of next generation therapeutic in-situ vaccine immunotherapy for cancer and infectious diseases where... - September 10, 2021 - Mirror Biologics, Inc.
Aelius LED Office Expansion Improves Efficiency for Cultivators Worldwide
Canadian LED Grow Light Experts Move Into New Facility - September 07, 2021 - AeliusLED
Defined Bioscience Licenses FGF2-STAB (G3) for Use in Stem Cell Media
Defined recently concluded a licensing agreement with Czech Republic-based Enantis for global use of Enantis’ patented FGF2-STAB® technology both alone and in stem cell media formulations. FGF2-STAB®, originally coined FGF2-G3, was developed by Enantis and Masaryk University, using... - August 30, 2021 - Defined Bioscience Inc.
Podcast on Vitiligo with Recouleur® Vitiligo Vitamin Creator Audrey VanStockum
The podcast entitled “The Journey with Vitiligo with Audrey VanStockum,” will air August 31, 2021 at 11:00 a.m. CST and can be heard live as well as recorded after the show on Blog Talk Radio. VanStockum will discuss treatments she tried, and how she created Recouleur. - August 25, 2021 - Supernatural Health, Inc.
Omni Healthcare Communications & Res Consortium Form Alliance to Expand Medical Affairs Capabilities
Omni Healthcare Communications (Omni-HC), a US based medical communications firm delivering solutions for today’s scientific exchange challenges, is pleased to announce the formation of a strategic alliance with Res Consortium (Res) of the United Kingdom, a cross-sector leader in digital... - August 21, 2021 - Sunny Ayr Holdings
UpSpring® Launches New U.Siip Line of Water Enhancers for Moms
UpSpring LLC, maker of clinically-backed health and wellness solutions for all stages of mom-hood, today announced it has launched U.Siip Water Enhancers with 4 key electrolytes specifically formulated for women who are pregnant or breastfeeding. - August 19, 2021 - Upspring LLC
Food is Medicinal: PRVZN CO Launches LUV Your Mood to Help Make Stress Less Stressful
To help people fight the negative effects of stress, global wellbeing company PRVZN CO LLC, a pioneer in the use of adaptogens, has launched LUV Your Mood. Its selection of ingredients utilizes a powerful blend of Ayurvedic medicine and modern research to create a naturally sound, science-backed supplement for its customers. The dietary supplement features nine adaptogens that support the body's ability to adapt to stress, combat fatigue, and improve mental clarity.* - August 10, 2021 - PRVZN CO LLC
ConSep II™ Filter Module, a Game Changer in Fermentation and High Temperature Cross Flow Filtration Applications
The combination of the patented open channel design and the high temperature capabilities of the ConSep II™ filter module provide unique performance characteristics which customers describe as an "enabling technology" and "a game changer." - July 29, 2021 - SmartFlow Technologies
Malaysia Thailand Collaboration to Increase the Affordability and Accessibility of Cancer Drugs in Thailand Through Local Manufacturing
Strategic collaboration between Malaysia and Thailand has been announced for technology and knowledge transfer to develop R&D and manufacturing of prescription drugs in the initiative to help millions of cancer patients in ASEAN region. - July 28, 2021 - Oncogen Pharma (Malaysia) Sdn Bhd
Microvascular Therapeutics Has Received Funds from the National Heart, Lung and Blood Institute (NHLBI)
Microvascular Therapeutics (MVT) has received funds from the from the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health for its program to treat cardiovascular disease, which kills more Americans than any other disease. As a leader in fluorocarbon... - July 19, 2021 - Microvascular Therapeutics, Inc.
Mirror Biologics, Inc. Announces Initiation of AlloStim® Phase I/II Universal Viral Vaccine Clinical Trial (ALLOPRIME) in Healthy Adults Over 65 Years Old
Mirror Biologics, Inc, (“Mirror Biologics” or the “Company”), a clinical stage immunotherapy company specializing in the development, manufacturing and clinical translation of next generation therapeutic in-situ vaccines for cancer and infectious diseases where the active... - July 14, 2021 - Mirror Biologics, Inc.
Mirror Biologics, Inc. Announces Initiation of AlloStim® Phase IIB Clinical Trial (STIMVAX) in Patients with Metastatic Colorectal Cancer
Mirror Biologics, Inc. (“Mirror Biologics” or the “Company”), a clinical stage immunotherapy company specializing in the development, manufacturing and clinical translation of next generation therapeutic in-situ cancer vaccines in which the active ingredients are living... - July 09, 2021 - Mirror Biologics, Inc.
Parvus Therapeutics Announces CEO, Senior Executive, and Board of Directors Appointments
Appoints CEO, Senior Executive, and Board of Directors: Peter M. Strumph, Chief Executive Officer; Brendan Classon PhD, Executive Vice President, Research and Development; Louis Demers, Vice President of Technical Operations; Matthew J. Hogan, member of the Board of Directors - July 06, 2021 - Parvus Therapeutics U.S., Inc.
Defined Bioscience Launches with $1.5M SBIR from the NIH to Advance Stem Cell Media
Defined recently received a $1.5M in Phase II SBIR award from the National Institutes of Health to develop defined media over the next two years. - July 03, 2021 - Defined Bioscience Inc.
Paras Biopharmaceuticals Finland Oy Named as One of the Top Pharma Outsourcing Companies in Europe 2021
Paras Biopharmaceuticals Highlights Company Innovations that Decode and Create Biologics Medicines for Unmet Medical Needs (Pharma Tech Outlook, USA) - June 22, 2021 - Paras Biopharmaceuticals Finland Oy
Targeted Pharmaceuticals and George Mason University Announce First-Ever Preclinical Study Using Cannabinoids in an Organoid Model
Study Examines the Effects of Cannabinoids Treating Central Nervous System (CNS) Viruses including HIV Associated Dementia - June 16, 2021 - Targeted Pharmaceuticals
GENINVO Launches Updated New Website
After months of hard work and dedication, GENINVO is pleased to announce the new and updated website launch. The primary goal of the redesign process was to create a user-focused design, add improved functionality, and provide easy access to information about GENINVO’s products and services. - June 14, 2021 - GenInvo, Inc.
PharmAbbie, Inc. Announces the Launch of a Reg D-506(c) Common Stock Offering
PharmAbbie, Inc. is pleased to announce today that it will offer up to 3,191,489 shares of its Class D Common Stock at an offering price of $4.70 per share for an aggregate offering amount of $15,000,000. The shares will be offered to accredited investors only pursuant to Regulation D, Rule 506(c)... - June 09, 2021 - PharmAbbie, Inc.
Thrivous Launches Omega Cardioprotector Formula 2
Thrivous, the human enhancement company, has released Omega Cardioprotector Formula 2. Omega is an advanced geroprotector supplement that Thrivous develops to enhance heart function and circulation for better aging. Omega formula 2 combines geroprotector nutrients with the highest levels of... - June 03, 2021 - Thrivous
MADSA Joins MAREA
The Malaysian Dietary Supplement Association joins the Malaysian Recycling Alliance to assist Members to play a more meaningful role in ESG and SDG to save the planet. - May 27, 2021 - Malaysian Dietary Supplement Association
Updated Findings of COVID-19 Impact on Biopharmaceutical Industry & CRO Outsourcing Report
2021 Survey Quantifies Current and Expected impact of COVID-19 on Clinical Development and CRO Outsourcing and Changes Since 2020 - May 25, 2021 - Life Science Strategy Group, LLC
eCTD Solutions Appoints New CEO and Changes Name to Highlight Expanded Capability
Sunny Ayr Holdings, a group of healthcare product solutions companies, is pleased to announce the change of the name of eCTD Solutions Ltd. to Omni Early Development Services and the appointment of Mark Marino, MD as Partner and Chief Executive Officer of the early product development solutions provider. - May 19, 2021 - Sunny Ayr Holdings
Advanced Silicon Group Closes Seed Preferred Equity Offering and Adds Alan Watson and Sarah Kelly to Board
Advanced Silicon Group, Inc. (ASG), a pioneer in silicon nanotechnology focused on developing novel biosensors, announced today the closing of a $1,020,000 seed preferred stock offering led by Cherrystone Angel Group with participation by MIT Alumni Angels of Northern California, Sidecar Angels and other private investors and the addition of two new Directors, Alan Watson, PhD, MBA and Sarah Kelly, PhD to its Board of Directors. - May 16, 2021 - Advanced Silicon Group
Cayman Develops Powerful, New Multiplex ELISA for Autoantibody Detection
Cayman Chemical's new Q-Plex™ Autoantibody Detection 10-Plex Panel, developed in collaboration with Quansys Biosciences, offers standardized, multiplex capabilities for the concurrent analysis of ten prominent analytes associated with rheumatoid arthritis or other autoimmune diseases. This... - May 16, 2021 - Cayman Chemical Company
Journal of Longevity Inc. (JOL) Announces the Launch of New Nutritional Supplement Line
Journal of Longevity, Inc. (JOL), a nutritional supplement startup company, is excited to announce the launch of a new health supplement line available now with vitamins and powder supplements for anyone looking to pursue a healthier lifestyle. The launch includes 18 products formulated with... - May 12, 2021 - Journal Of Longevity Inc.
A New Anti-Aging Agent is Making Its Way Into Skincare, and the Results Are on Par with Many Cosmetic Procedures
Topical NAD+ products, previously available by prescription, are exploding onto the aesthetic scene. In 2020, Avior Nutritionals, the makers of Real NAD+, released a nonprescription skincare product that boasts more than twice the amount of NAD+ as its prescription predecessor. Avior’s... - May 07, 2021 - Avior Nutritionals- NADIA Skin
MedShorts Announces Promotion of Blake Powers to President
MedShorts, an Orlando-based e-commerce software solution specializing in connecting pharmacies with pharmaceutical manufacturers to source short-dated and short-supply medications, announced the promotion of Blake Powers to President of the company. After serving as the company’s Chief Operating Officer over the past five years, Blake has advanced to leading the company at a time when hospitals face significant financial pressure to reduce costs within their facilities. - May 06, 2021 - MedShorts LLC
Paras Biopharmaceuticals Finland Oy is Named as One of the Top 30 Admired Companies to Watch 2021
Paras Biopharmaceuticals Finland Oy, a fast-growing, biopharmaceutical technology development company, based in Oulu, Finland, announced today that it is named as one of the top 30 admired companies to watch during 2021, by CIO Bulletin, USA. - April 28, 2021 - Paras Biopharmaceuticals Finland Oy
Linshom Receives SBIR Phase II Contract Award from the United States Air Force for Its Dual Purpose Respiratory Device
Linshom announced today receipt of a phase II SBIR contract award with the United States Air Force (USAF) to fund ongoing development and deployment of the Linshom Predictive Continuous Respiratory Monitoring (LPCRM) System. The $748K contract follows successful completion of a SBIR phase 1 award... - April 27, 2021 - Linshom
Careington Announces Completion of New Corporate Campus in Frisco
Careington International Corporation celebrated the recent completion of its new corporate campus located in Frisco, Texas. This facility is an addition to Careington’s international headquarters, which includes two buildings also located in Frisco. This new campus was developed to address... - April 23, 2021 - Careington
Court Square Group and 5thPort Announce Life Science Industry Partnership
Court Square Group and 5thPort’s Partnership helps life science companies streamline clinical trials and procedures, increase regulatory compliance, and shorten time to market. - April 15, 2021 - Court Square Group
Families of World War II Veterans Takes Part in Frisco Veteran’s 100th Birthday Celebration
Families of World War II Veterans is excited to announce it took part in a special birthday celebration in Frisco in honor of World War II veteran Burnie Sutter’s 100th birthday on Saturday, April 10. To help commemorate the birthday of this war hero, Families of World War II Veterans... - April 11, 2021 - Careington
Newest Weapon in the Fight Against COVID 19 - Bi-Polar Ionization System Tests Positive for Killing Coronavirus
The scientific study was conducted by Hylabs and followed the stringent guidelines developed by the Israeli Ministry of Health. The tests concluded that the Sterionizer D6 and D5 units were capable of inactivating hCoV-OC43; an acceptable model for SARS-CoV-2 which causes COVID-19. Medcare Medical Devices Canada is a Canadian importer and authorized distributor of the Sterionizer family of ionizer systems. They have the products registered under their MDEL license with Health Canada. - March 25, 2021 - MedCare Medical Devices Canada
Portland Trainer Attempts to Break World Record for Heaviest Weight Lifted by Kettlebell Swing
To demonstrate the incredible power of consistency and the body's ability to heal, Portland-based personal trainer and life enhancement enthusiast Steven Herrera will be continuously swinging a kettlebell through a full range of motion for an hour straight. Herrera is taking on this challenge in an effort to break the current Guinness World Record and also hopes to raise awareness for diabetes. - March 18, 2021 - Stick-To-It Fitness
MEDraysintell Publishes Its New Proton Therapy World Report & Directory, Edition 2021
Proton therapy market headwinds: demand down, supply up, but increasing awareness. - March 06, 2021 - MEDraysintell
Intrinsic Imaging Undergoes Third FDA Inspection with No 483 Observations
Intrinsic Imaging recently underwent an extensive inspection by the U.S. Food and Drug Administration (FDA). The FDA determined Intrinsic Imaging was in complete compliance with all federal regulations and the company received zero 483 observations. This was Intrinsic Imaging's third FDA inspection and its third inspection with no findings. - March 01, 2021 - Intrinsic Imaging, LLC
Paras Biopharmaceuticals Finland Oy Affordable Healthcare Efforts Viewed in Over 90 Countries: Biosimilar Technologies Get Attention
Paras Biopharmaceuticals Finland Oy (Paras Biopharma) is a Finland-based microbial biologics company which focuses on the development of technologies for biosimilars and biologics in an efficient manner. The overall objective of Paras Biopharma is to enable economical production and future availability of affordable medicines for unmet medical needs. - February 17, 2021 - Paras Biopharmaceuticals Finland Oy
Cayman Adds Nordic BioSite as Trusted Distributor
Cayman Chemical’s complete assay kit, protein, antibody, and biochemical portfolio is now more accessible to Denmark, Finland, Iceland, Norway, Sweden, and the Baltic countries as well as Russia through a distribution agreement with Nordic BioSite. Headquartered in Täby, Sweden, Nordic... - February 10, 2021 - Cayman Chemical Company
Careington® Announces Launch of National Teledentistry Program
Careington is introducing an innovative teledentistry program through affiliate company DialCare. - February 05, 2021 - Careington
Careington, a Proud Sponsor of Annual Dr. Martin Luther King, Jr. Essay and Oration Scholarship Competition
Careington is proud to have once again served as a "Dream" level sponsor for the 11th annual Dr. Martin Luther King, Jr. Essay and Oration Scholarship competition. This annual event is hosted by Linking Cultures of Frisco, a Frisco-based non-profit organization with a mission to connect... - January 29, 2021 - Careington
Linshom Announces European Patent Coverage for the Linshom Continuous Respiratory Monitor
Linshom announced today receipt of patents in five European countries including Germany, France, Spain, Italy and Great Britain. This adds to and expands the current Linshom patent portfolio held in the United States, Canada, Japan, Mexico and China. The lack of a simple, portable and inexpensive... - January 28, 2021 - Linshom
AltuCell Therapeutics Announces Proof-of-Concept in Lead Programs in Type 1 Diabetes in Human Subjects; Phase 1 Pilot in Humans Has IND Approval & Trial to Begin Shortly
AltuCell Therapeutics, Inc., AltuCell announced today the achievement of approval of IND in Italy after pre-clinical proof-of-concept based on data from its two lead programs for type 1 diabetes testing of cadaver stem cell-derived islets in both human and non-human subjects. Their capsules have been implanted in people with diabetes for 5 year, demonstrating long-term safety, with no toxicity or tissue necrosis, and no rejection in any of the patients treated. - January 15, 2021 - AltuCell Therapeutics
Careington Announces Launch of Get More Rx Discount Prescription Program Mobile App
Careington announces launch of Get More Rx Discount Prescription Program Mobile App after national program launch in 2020. - January 15, 2021 - Careington
MedCare Medical Devices Canada Introduces Osentia Test Kit - New Weapon in the Fight Against Osteoporosis
Osentia is a patented, Health Canada approved, professional laboratory test that uses Raman Spectroscopy screening technology to assess a patient’s risk of fragility fractures due to Osteoporosis. - December 31, 2020 - MedCare Medical Devices Canada
A Novel Treatment Modality for COVID-19: Global Cancer Technology is Developing a Nanoparticle Which May Selectively Target, Bind and Inactivate Coronavirus Virions
Global Cancer Technology, an emerging biopharmaceutical company, is developing a novel treatment modality to selectively kill the COVID-19 virus. - December 30, 2020 - Global Cancer Technology
OKAN Launches Hot Flash Relief, Maca and Ashwagandha by OKAN Vitamins
OKAN, a start-up in the women’s health and wellness industry and the maker of OKAN Vitamins, today announced the launch of Hot Flash Relief, Maca and Ashwagandha by OKAN Vitamins (www.okanvitamins.com). This new women’s vitamin line addresses issues of menstruation, menopause, and the... - December 28, 2020 - OKAN Vitamins
Families of World War II Veterans Holds Annual Fundraiser
Families of World War II Veterans held its annual fundraising event last month. Veterans, sponsors and special guests attended this year’s virtual event to honor our nation’s veterans and contribute to the Families of World War II Veterans scholarship fund. The Families of World War II... - December 17, 2020 - Careington